A brain region affected very early in Alzheimer's disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new study, published in the ...
Researchers have uncovered how certain genetic mutations lead to unique spherical amyloid plaques in inherited forms of ...
33m
A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid ...
A living will or living trust can also provide additional instructions for how your sister wishes her estate to be handled after her death. Crucially, a trust would help her executor, or the ...
Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the ...
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
A research group at LMU University Hospital has investigated how Alzheimer's disease can be diagnosed more reliably in the future.
Cassava Sciences’ phase 3 Alzheimer’s disease trial has missed its co-primary endpoints. With the study also missing ...
Modeled after the state’s $6B cancer research fund, the dementia fund could pump hundreds of millions of dollars into Texas ...
Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals in a late-stage study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback